Clinical Trial Update: Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether dietary supplementation with the probiotic Lactobacillus reuteri can reduce colic in infants. The current status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Colic

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Children's Investigational Research Program, LLC | Conditions: Colic | Phase 4 | Status: UNKNOWN